SAB Biotherapeutics (SABS) Return on Sales [ROS] (2021 - 2026)
SAB Biotherapeutics (SABS) recorded Return on Sales [ROS] of -8726.26% in Q4 2024, down 2538.36 percentage points from -6187.90% a year earlier and down 5303.59 percentage points from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
For FY2024, SAB Biotherapeutics reported Return on Sales [ROS] of -3244.87%, down 1544.32 percentage points from FY2023.
- Annual Return on Sales [ROS] has declined for four straight years, with a four-year change of -3282.09 percentage points (FY2020 to FY2024).
- Across earlier years, Return on Sales [ROS] came in at -1700.56% in FY2023 (-1579.58 pp), -120.97% in FY2022 (-98.97 pp), -22.00% in FY2021 (-59.22 pp) and 37.22% in FY2020.
- The Q4 2024 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q1 2021.
- On a year-over-year basis, Return on Sales [ROS] rose in two of the last eight quarters, with an average year-over-year change of -2061.34 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 3696.44 percentage points in Q2 2024, against a drop of 7470.37 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -3422.67% (Q3 2024), -3876.95% (Q2 2024) and -1205.90% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | -1,610.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,610.63% |
| Sep 30, 2025 | -2,071.73% |
| Dec 31, 2024 | -8,726.26% |
| Sep 30, 2024 | -3,422.67% |
| Jun 30, 2024 | -3,876.95% |
| Mar 31, 2024 | -1,205.90% |
| Dec 31, 2023 | -6,187.90% |
| Sep 30, 2023 | -420.00% |
| Jun 30, 2023 | -7,573.40% |
| Mar 31, 2023 | -1,273.79% |
| Dec 31, 2022 | -363.74% |
| Sep 30, 2022 | -217.49% |
| Jun 30, 2022 | -103.03% |
| Mar 31, 2022 | -56.83% |
| Dec 31, 2021 | -66.41% |
| Sep 30, 2021 | -27.18% |
| Jun 30, 2021 | -15.77% |
| Mar 31, 2021 | 4.81% |
API Access
SAB Biotherapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();